Close

JPMorgan Upgrades Pacific Biosciences of California (PACB) to Neutral

May 1, 2014 8:28 AM EDT
Get Alerts PACB Hot Sheet
Price: $3.86 +3.76%

Rating Summary:
    12 Buy, 8 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 13 | Down: 10 | New: 11
Join SI Premium – FREE

JPMorgan upgraded Pacific Biosciences of California (NASDAQ: PACB) from Underweight to Neutral with a price target of $7.00 (unchanged)

For an analyst ratings summary and ratings history on Pacific Biosciences of California click here. For more ratings news on Pacific Biosciences of California click here.

Shares of Pacific Biosciences of California closed at $4.42 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Upgrades

Related Entities

JPMorgan